Status ongoing projects

Glactone Pharma

(Immuno-oncology)

 
Exit
Phase II/III
Phase I
Preclinical

Oncorena

(Kidney cancer)

 
Exit
Phase II/III
Phase I
Preclinical

Adenovir Pharma

(Eye infection)

 
Exit
Phase II/III
Phase I
Preclinical

Trophea

(Skin atrophy)

 
Exit
Phase II/III
Phase I
Preclinical

Belina

(Breast cancer)

 
Exit
Phase II/III
Phase I
Preclinical

Do not hesitate to contact us

Headquarters

Kullagatan 8,
SE-252 20 Helsingborg, Sweden

Regional office

Sahlgrenska Science Park, Medicinaregatan 8A,
SE-413 46 Gothenburg, Sweden